"Alaska Regional Hospital has served the Anchorage, Alaska community for more than 50 years. We provide 24 hour emergency care, labor and delivery, cardiology care and a full list of other hospital services. Check out current ER wait times on our website."

During the past decade, Alaska Regional Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 28 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 22 clinical trials were completed. i.e. 2200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alaska Regional Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 19 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "GOG Foundation" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Regional Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 31 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator and "NRG Oncology" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Regional Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (5 trials), "Stage IIIA Breast Cancer" (4 trials), "Breast Adenocarcinoma" (3 trials) and "Lung Cancer" (3 trials). Many other conditions were trialed in "Alaska Regional Hospital" in a lesser frequency.

Most popular intervention types in "Alaska Regional Hospital" are "Drug" (44 trials), "Other" (35 trials), "Biological" (20 trials), "Procedure" (9 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (25 trials), "Quality-of-Life Assessment" (11 trials), "Docetaxel" (7 trials), "Nivolumab" (6 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Regional Hospital" are 40 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Alaska Regional Hospital". undefined are not yet recruiting, 4 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Alaska Regional Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Regional Hospital, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Alaska Regional Hospital has several departments that took part in Clinical trials: "Alaska Regional Hospital Cancer Center" - 29 trials